alexa
Reach Us +441730450007
Editor - Bobby Thomas | Georgia Health Science University | 14851
ISSN: 2329-6895

Journal of Neurological Disorders
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Bobby Thomas

Bobby Thomas
Bobby Thomas, PhD
Associate Professor
Departments of Pharmacology & Toxicology and Neurology
Georgia Health Science University
USA
Tel: 706-721-6356
Fax: 706-721-2347

Biography

Dr. Bobby Thomas is an Associate Professor of the Department of Pharmacology & Toxicology and Neurology in Georgia Health Science University. He completed his Ph.D. from Indian Institute of Chemical Biology, Jadavpur University, Kolkata in 2002. Dr. Bobby Thomas major interest is to study molecular mechanisms of neurodegeneration induced by genetic mutations, environmental toxicants and gene-environment interactions in Parkinson’s disease with a primary focus on mitochondrial dysfunction and stress signaling pathways involving oxidative stress and neuroinflammation.

Research Interest

Dr. Bobby Thomas main research is to study molecular mechanisms of neurodegeneration induced by genetic mutations, environmental toxicants and gene-environment interactions in Parkinson’s disease with a primary focus on mitochondrial dysfunction and stress signaling pathways involving oxidative stress and neuroinflammation. The ultimate goal is to utilize this mechanistic knowledge to develop tangible neuroprotective therapies for Parkinson's disease and perhaps other neurodegenerative disorders. Experimental approach is to use both genetic and toxicant induced cell culture and mouse models of Parkinson's disease, patient derived iPS cells and postmortem tissues. Major techniques that are routinely used in our lab include stereotactic surgery, HPLC, stereological cell counting, confocal imaging, immunohistochemistry and other standard molecular biology methods such as immunoblotting, RT-PCR, gene cloning, lentiviral and adeno-associated virus mediated gene transfer, magnetic cell sorting and flow cytometry.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Relevant Topics
Top